M.A.M. Berends

Biochemical and biophysical assessment of MTX‐induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan^® predicts the absence of significant liver fibrosis

M.A.M. Berends, Josje Snoek, E.M.G.J. de Jong et al. · Liver International · 2007 · 83 citations

Medicine, Pathology, Hepatic Pharmacotherapy +16

Liver injury in long‐term methotrexate treatment in psoriasis is relatively infrequent

M.A.M. Berends, Josje Snoek, E.M.G.J. de Jong et al. · Alimentary Pharmacology & Therapeutics · 2006 · 80 citations

Medicine, Dermatology, Pharmacotherapy +16

Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-t

Jeffrey Zweegers, J.M.P.A. van den Reek, P.C.M. van de Kerkhof et al. · British Journal of Dermatology · 2016 · 78 citations

Medicine, Pharmacology, Pharmacotherapy +13

The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T‐cell subsets in chronic plaque psoriasis

W.H.P.M. Vissers, M.A.M. Berends, Leon Muys et al. · Experimental Dermatology · 2004 · 60 citations

Medicine, Dermatology, Pharmacotherapy +13

Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry

Jeffrey Zweegers, J.M.M. Groenewoud, J. M. P. A. van den Reek et al. · British Journal of Dermatology · 2016 · 54 citations

Medicine, Dermatology, Pharmacotherapy +11